Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

31 Aug 2007 15:39

Oxford Biomedica PLC31 August 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): MF Global UK Limited 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 29 August 2007 6. Date on which issuer notified: 30 August 2007 7. Threshold(s) that is/are crossed or reached: 3% 8. Notified details: 3.43% A: Voting rights attached to shares Class/type of shares Situation previous to the Triggering transactionif possible using (vi)the ISIN CODE Number of shares Number of voting Rights (viii) GB0006648157 Below 3% Below 3% Resulting situation after the triggering transaction (vii)Class/type of shares Number of shares Number of voting % of votingif possible using rights (ix) rightsthe ISIN CODE Direct Direct (x) Indirect Direct Indirect (xi) GB0006648157 18,325,176 18,325,176 3.43% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date Exercise/Conversion Number of voting % of votingfinancial (xiii) Period/Date (xiv) rights that may be rightsinstrument acquired if the instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 18,325,176 3.43% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): MF Global UK Limited Contact address (registered office for legal entities): Phone number: Other useful information (at least legal representative for legal persons): B: Identity of the notifier, if applicable (xvii) Full name: Contact address: Phone number: This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jan 20212:09 pmRNSBlock Listing Return
4th Jan 20211:41 pmRNSTotal Voting Rights
30th Dec 20209:03 amRNSOXB notes AZ vaccine has been authorised in the UK
1st Dec 202012:17 pmRNSDirector Dealings
1st Dec 20209:02 amRNSTotal Voting Rights
23rd Nov 20208:47 amRNSOXB notes AZD1222 met primary efficacy endpoint
23rd Nov 20207:00 amRNSNon-Executive Director Appointment
9th Nov 20207:00 amRNSOXB and PhoreMost enter gene therapy collaboration
2nd Nov 20209:02 amRNSTotal Voting Rights
30th Oct 20207:00 amRNSAxovant update on AXO-Lenti-PD and virtual R&D day
23rd Oct 202010:27 amRNSDirector Purchase
12th Oct 20205:38 pmRNSHolding(s) in Company
6th Oct 202012:46 pmRNSAxovant update on 2nd cohort of SUNRISE-PD trial
6th Oct 20207:00 amRNSOXB receives approval for fourth suite in Oxbox
5th Oct 202010:59 amEQSEdison Investment Research Limited: Oxford Biomedica (OXB): Vector innovation key to cell and gene evolution
2nd Oct 202011:52 amRNSTotal Voting Rights
29th Sep 20203:51 pmRNSDirector Dealings
24th Sep 20209:36 amRNSDirector/PDMR Shareholding
22nd Sep 202012:54 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSInterim Results
1st Sep 20209:33 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSMaster Supply and Development Agreement with AZ
27th Aug 20207:00 amRNSNotice of Interim Results
25th Aug 20204:46 pmRNSBlock listing Application
3rd Aug 20209:41 amRNSTotal Voting Rights
3rd Aug 20207:00 amRNSOXB signs DMLA with Beam Therapeutics
31st Jul 20207:00 amRNSOXB Signs Clinical Supply Agreement with Axovant
20th Jul 20204:23 pmRNSOXB notes interim results from AZ on AZD1222
3rd Jul 202010:45 amRNSDirector Dealings / Market Share Purchase
2nd Jul 20203:39 pmRNSDirector Dealings / Market Share Purchase
2nd Jul 20201:34 pmRNSDirector Dealings / Market Share Transactions
1st Jul 20206:30 pmRNSHoldings in Company
1st Jul 20203:44 pmRNSBlock listing Return
1st Jul 20209:13 amRNSTotal Voting Rights
30th Jun 20203:23 pmRNSGrant of options
25th Jun 20209:44 amRNSHolding(s) in Company
24th Jun 202011:45 amRNSHoldings in Company
24th Jun 20209:54 amRNSDirector Dealings / Share Disposal – Replacement
24th Jun 20207:00 amRNSDirector Dealings / Market Share Purchase
23rd Jun 20204:46 pmRNSResult of Annual General Meeting
23rd Jun 20202:47 pmRNSAdmission of shares and Total Voting Rights.
23rd Jun 20207:00 amRNSAnnual General Meeting
19th Jun 20203:26 pmRNSInformation in Relation to Annual General Meeting
19th Jun 20207:00 amRNSResult of Placing
18th Jun 20205:33 pmRNSProposed Placing of new Ordinary Shares
8th Jun 20204:01 pmRNSUpdate on Sanofi Ophthalmology Programmes
8th Jun 20207:00 amRNSFive Year Collaboration Agreement signed with VMIC
1st Jun 20209:06 amRNSTotal Voting Rights
1st Jun 20207:00 amRNSDr Roch Doliveux appointed Non-Executive Chairman
28th May 202012:16 pmRNSClinical & Commercial Supply Agreement with AZ

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.